SI-BONE Inc
NASDAQ:SIBN

Watchlist Manager
SI-BONE Inc Logo
SI-BONE Inc
NASDAQ:SIBN
Watchlist
Price: 14.41 USD 0.14% Market Closed
Market Cap: 611.7m USD

Wall Street
Price Targets

SIBN Price Targets Summary
SI-BONE Inc

Wall Street analysts forecast SIBN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SIBN is 24.86 USD with a low forecast of 19.19 USD and a high forecast of 33.6 USD.

Lowest
Price Target
19.19 USD
33% Upside
Average
Price Target
24.86 USD
73% Upside
Highest
Price Target
33.6 USD
133% Upside
SI-BONE Inc Competitors:
Price Targets
FPH
Fisher & Paykel Healthcare Corporation Ltd
8% Upside
PRCT
Procept Biorobotics Corp
80% Upside
7817
Paramount Bed Holdings Co Ltd
16% Upside
228850
Rayence Co Ltd
22% Upside
MOVE
Medacta Group SA
18% Upside
LMAT
LeMaitre Vascular Inc
18% Upside
4543
Terumo Corp
23% Upside
IRTC
iRhythm Technologies Inc
25% Upside

Revenue
Forecast

Revenue Estimate
SI-BONE Inc

For the last 8 years the compound annual growth rate for SI-BONE Inc's revenue is 19%. The projected CAGR for the next 3 years is 16%.

19%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
SI-BONE Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
SI-BONE Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-24%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SIBN's stock price target?
Price Target
24.86 USD

According to Wall Street analysts, the average 1-year price target for SIBN is 24.86 USD with a low forecast of 19.19 USD and a high forecast of 33.6 USD.

What is SI-BONE Inc's Revenue forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for SI-BONE Inc's revenue is 19%. The projected CAGR for the next 3 years is 16%.

Back to Top